JPMorgan Chase & Co. Sells 799,246 Shares of Adaptive Biotechnologies Corporation $ADPT

JPMorgan Chase and Co. lowered its stake in shares of Adaptive Biotechnologies Corporation (NASDAQ: ADPT) by 77.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 235,668 shares of the company's stock after selling 799,246 shares during the quarter. JPMorgan Chase and Co.